SG11201401591WA - Solid forms of 1,l-dioxo-4-thiomorpholinyl)-[6-[[3(4-fluorophenyl)-5-methyl-4-isoxazolyl]methoxy]-3-pyridinyl]-methanone - Google Patents
Solid forms of 1,l-dioxo-4-thiomorpholinyl)-[6-[[3(4-fluorophenyl)-5-methyl-4-isoxazolyl]methoxy]-3-pyridinyl]-methanoneInfo
- Publication number
- SG11201401591WA SG11201401591WA SG11201401591WA SG11201401591WA SG11201401591WA SG 11201401591W A SG11201401591W A SG 11201401591WA SG 11201401591W A SG11201401591W A SG 11201401591WA SG 11201401591W A SG11201401591W A SG 11201401591WA SG 11201401591W A SG11201401591W A SG 11201401591WA
- Authority
- SG
- Singapore
- Prior art keywords
- methanone
- thiomorpholinyl
- dioxo
- isoxazolyl
- pyridinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11185993 | 2011-10-20 | ||
| PCT/EP2012/070522 WO2013057124A1 (en) | 2011-10-20 | 2012-10-17 | Solid forms of 1,l-dioxo-4-thiomorpholinyl)-[6-[[3(4-fluorophenyl)-5-methyl-4-isoxazolyl]methoxy]-3-pyridinyl]-methanone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201401591WA true SG11201401591WA (en) | 2014-05-29 |
Family
ID=47019027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201401591WA SG11201401591WA (en) | 2011-10-20 | 2012-10-17 | Solid forms of 1,l-dioxo-4-thiomorpholinyl)-[6-[[3(4-fluorophenyl)-5-methyl-4-isoxazolyl]methoxy]-3-pyridinyl]-methanone |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US8785435B2 (en) |
| EP (1) | EP2768821B1 (en) |
| JP (1) | JP5918856B2 (en) |
| KR (1) | KR20140079503A (en) |
| CN (1) | CN103889971B (en) |
| AR (1) | AR088359A1 (en) |
| AU (1) | AU2012318294B2 (en) |
| BR (1) | BR112014009288A8 (en) |
| CA (1) | CA2850441A1 (en) |
| DK (1) | DK2768821T3 (en) |
| ES (1) | ES2606547T3 (en) |
| HK (1) | HK1193611A1 (en) |
| HU (1) | HUE030298T2 (en) |
| IL (1) | IL231532A0 (en) |
| MX (1) | MX341492B (en) |
| PL (1) | PL2768821T3 (en) |
| RU (1) | RU2618524C2 (en) |
| SG (1) | SG11201401591WA (en) |
| SI (1) | SI2768821T1 (en) |
| WO (1) | WO2013057124A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2792360A1 (en) | 2013-04-18 | 2014-10-22 | IP Gesellschaft für Management mbH | (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV |
| MX2020002196A (en) * | 2017-08-28 | 2020-09-28 | Univ Maryland | Novel gamma aminobutyric acid type a receptor modulators for mood disorders. |
| AU2019286312B2 (en) | 2018-06-13 | 2023-08-17 | F. Hoffmann-La Roche Ag | New isoxazolyl ether derivatives as GABA A alpha5 PAM |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE352505C (en) | 1918-03-01 | 1922-04-27 | Metallbank | Method for processing ammonia slag |
| DE3525205A1 (en) | 1984-09-11 | 1986-03-20 | Hoechst Ag, 6230 Frankfurt | PLANT PROTECTIVE AGENTS BASED ON 1,2,4-TRIAZOLE DERIVATIVES AND NEW DERIVATIVES OF 1,2,4-TRIAZOLE |
| GB9808663D0 (en) | 1998-04-23 | 1998-06-24 | Merck Sharp & Dohme | Therapeutic agents |
| US6262098B1 (en) | 1998-08-07 | 2001-07-17 | Chiron Corporation | Estrogen receptor modulators |
| US6297256B1 (en) | 1999-06-15 | 2001-10-02 | Neurogen Corporation | Aryl and heteroaryl substituted pyridino derivatives GABA brain receptor ligands |
| US6660753B2 (en) | 1999-08-19 | 2003-12-09 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| IT1314191B1 (en) | 1999-10-18 | 2002-12-06 | Recordati Chem Pharm | ISOSSAZOLCARBOSSAMIDIC DERIVATIVES |
| US6511987B1 (en) | 1999-11-12 | 2003-01-28 | Neurogen Corporation | Bicyclic and tricyclic heteroaromatic compounds |
| PA8535601A1 (en) | 2000-12-21 | 2002-11-28 | Pfizer | BENZIMIDAZOL AND PIRIDILIMIDAZOL DERIVATIVES AS LIGANDOS FOR GABAA |
| GB0108475D0 (en) | 2001-04-04 | 2001-05-23 | Merck Sharp & Dohme | New compounds |
| CN1671386A (en) | 2001-07-05 | 2005-09-21 | H·隆德贝克有限公司 | Substituted anilinic piperidines as MCH selective antagonists |
| ATE381542T1 (en) | 2001-08-13 | 2008-01-15 | Phenex Pharmaceuticals Ag | NR1H4 CORE RECEPTOR BINDING COMPOUNDS |
| AU2002353844A1 (en) | 2001-11-20 | 2003-06-10 | Eli Lilly And Company | Beta 3 adrenergic agonists |
| GB0128160D0 (en) | 2001-11-23 | 2002-01-16 | Merck Sharp & Dohme | Novel compounds |
| GB0128499D0 (en) | 2001-11-28 | 2002-01-23 | Merck Sharp & Dohme | Therapeutic agents |
| WO2004048349A1 (en) | 2002-11-22 | 2004-06-10 | Smithkline Beecham Corporation | Farnesoid x receptor agonists |
| GB0318447D0 (en) | 2003-08-05 | 2003-09-10 | Merck Sharp & Dohme | Therapeutic agents |
| KR20070034993A (en) | 2004-05-14 | 2007-03-29 | 아이알엠 엘엘씨 | Compounds and Compositions as PPA Regulators |
| EP1756086B1 (en) | 2004-06-01 | 2008-06-04 | F.Hoffmann-La Roche Ag | Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists |
| JP2008502687A (en) | 2004-06-14 | 2008-01-31 | タケダ サン ディエゴ インコーポレイテッド | Kinase inhibitor |
| CA2581945C (en) | 2004-10-01 | 2011-01-18 | Henrietta Dehmlow | Hexafluoroisopropanol substituted ether derivatives |
| WO2006044617A1 (en) | 2004-10-15 | 2006-04-27 | The Scripps Research Institute | Oxadiazole ketone inhibitors of fatty acid amide hydrolase |
| US20070060589A1 (en) | 2004-12-21 | 2007-03-15 | Purandare Ashok V | Inhibitors of protein arginine methyl transferases |
| WO2006095822A1 (en) | 2005-03-11 | 2006-09-14 | Ono Pharmaceutical Co., Ltd. | Sulfonamide compound and pharmaceutical thereof |
| DE602006017694D1 (en) | 2005-06-27 | 2010-12-02 | Bristol Myers Squibb Co | C-LINKED CYCLIC ANTAGONISTS OF THE P2Y1 RECEPTOR SUITABLE FOR THE TREATMENT OF THROMBOTIC SUFFERING |
| ATE484416T1 (en) | 2005-07-20 | 2010-10-15 | Prospective Concepts Ag | PNEUMATICALLY ADJUSTABLE SIDE CHEERS FOR VEHICLE SEATS |
| AU2006298867A1 (en) | 2005-09-19 | 2007-04-12 | F. Hoffmann-La Roche Ag | Isoxazolo derivatives as GABA A alpha5 inverse agonists |
| AU2006301376A1 (en) | 2005-10-11 | 2007-04-19 | F. Hoffmann-La Roche Ag | Isoxazole derivatives |
| WO2007052843A1 (en) | 2005-11-04 | 2007-05-10 | Takeda Pharmaceutical Company Limited | Heterocyclic amide compound and use thereof |
| AU2006319232B2 (en) * | 2005-11-30 | 2012-09-13 | F. Hoffmann-La Roche Ag | 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as H3 modulators |
| WO2007076260A2 (en) | 2005-12-19 | 2007-07-05 | Smithkline Beecham Corporation | Farnesoid x receptor agonists |
| WO2007071476A1 (en) * | 2005-12-20 | 2007-06-28 | International Business Machines Corporation | Method, system and computer program for distributing software products based on an e-mail service |
| BRPI0707427A2 (en) | 2006-02-03 | 2011-05-03 | Lilly Co Eli | a compound or a pharmaceutically acceptable salt thereof, a method for treating dyslipidemia, atherosclerosis, and diabetes and complications thereof, to elevate plasma levels of hdl, and to decrease plasma triglycerides, pharmaceutical composition, and use of a compound or salt. pharmaceutically acceptable thereof |
| JP2007230909A (en) | 2006-03-01 | 2007-09-13 | Univ Of Tokyo | Substituted isoxazole derivative |
| ES2328185T3 (en) | 2006-05-31 | 2009-11-10 | F. Hoffmann-La Roche Ag | DERIVATIVES OF ARIL-4-ETINIL-ISOXAZOL. |
| EP1894924A1 (en) | 2006-08-29 | 2008-03-05 | Phenex Pharmaceuticals AG | Heterocyclic FXR binding compounds |
| EP1894928A1 (en) | 2006-08-29 | 2008-03-05 | PheneX Pharmaceuticals AG | Heterocyclic fxr binding compounds |
| CN101687873A (en) | 2007-04-17 | 2010-03-31 | 百时美施贵宝公司 | 11 beta-hydroxysteroid dehydrogenase type i inhibitors with annelated heterocycles |
| CN101883769B (en) | 2007-12-04 | 2012-08-08 | 弗·哈夫曼-拉罗切有限公司 | Isoxazolo-pyrazine derivatives |
| DK2767536T3 (en) | 2007-12-04 | 2015-10-19 | Hoffmann La Roche | Isoxazolo-pyridine derivatives |
-
2012
- 2012-10-12 US US13/650,159 patent/US8785435B2/en active Active
- 2012-10-17 CN CN201280051089.3A patent/CN103889971B/en active Active
- 2012-10-17 AR ARP120103860A patent/AR088359A1/en unknown
- 2012-10-17 SI SI201230792A patent/SI2768821T1/en unknown
- 2012-10-17 AU AU2012318294A patent/AU2012318294B2/en not_active Ceased
- 2012-10-17 RU RU2014118968A patent/RU2618524C2/en not_active IP Right Cessation
- 2012-10-17 HU HUE12772789A patent/HUE030298T2/en unknown
- 2012-10-17 DK DK12772789.9T patent/DK2768821T3/en active
- 2012-10-17 PL PL12772789T patent/PL2768821T3/en unknown
- 2012-10-17 MX MX2014004678A patent/MX341492B/en active IP Right Grant
- 2012-10-17 EP EP12772789.9A patent/EP2768821B1/en active Active
- 2012-10-17 SG SG11201401591WA patent/SG11201401591WA/en unknown
- 2012-10-17 WO PCT/EP2012/070522 patent/WO2013057124A1/en active Application Filing
- 2012-10-17 ES ES12772789.9T patent/ES2606547T3/en active Active
- 2012-10-17 KR KR1020147013555A patent/KR20140079503A/en active Search and Examination
- 2012-10-17 JP JP2014536209A patent/JP5918856B2/en active Active
- 2012-10-17 CA CA2850441A patent/CA2850441A1/en not_active Abandoned
- 2012-10-17 BR BR112014009288A patent/BR112014009288A8/en not_active IP Right Cessation
-
2014
- 2014-03-13 IL IL231532A patent/IL231532A0/en active IP Right Grant
- 2014-06-04 US US14/295,535 patent/US8975397B2/en active Active
- 2014-07-09 HK HK14106993.8A patent/HK1193611A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112014009288A2 (en) | 2017-06-13 |
| RU2618524C2 (en) | 2017-05-04 |
| JP2014530832A (en) | 2014-11-20 |
| CN103889971B (en) | 2016-08-31 |
| HK1193611A1 (en) | 2014-09-26 |
| SI2768821T1 (en) | 2017-01-31 |
| US20140329806A1 (en) | 2014-11-06 |
| EP2768821A1 (en) | 2014-08-27 |
| MX341492B (en) | 2016-08-23 |
| HUE030298T2 (en) | 2017-04-28 |
| AR088359A1 (en) | 2014-05-28 |
| PL2768821T3 (en) | 2017-05-31 |
| MX2014004678A (en) | 2014-05-28 |
| AU2012318294A1 (en) | 2013-05-09 |
| CA2850441A1 (en) | 2013-04-25 |
| DK2768821T3 (en) | 2017-01-23 |
| BR112014009288A8 (en) | 2020-04-22 |
| US8785435B2 (en) | 2014-07-22 |
| RU2014118968A (en) | 2015-11-27 |
| ES2606547T3 (en) | 2017-03-24 |
| KR20140079503A (en) | 2014-06-26 |
| CN103889971A (en) | 2014-06-25 |
| AU2012318294B2 (en) | 2015-10-01 |
| US20130172329A1 (en) | 2013-07-04 |
| IL231532A0 (en) | 2014-04-30 |
| US8975397B2 (en) | 2015-03-10 |
| JP5918856B2 (en) | 2016-05-18 |
| WO2013057124A1 (en) | 2013-04-25 |
| EP2768821B1 (en) | 2016-11-16 |
| NZ622215A (en) | 2016-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1196371A1 (en) | Substituted imidazopyridinyl aminopyridine compounds | |
| IL235745A (en) | 2-aminopyridine derivatives | |
| EP2671582A4 (en) | Ring-fused heterocyclic derivative | |
| ZA201201125B (en) | Pyridin-4-yl derivatives | |
| EP2703394A4 (en) | Novel 3-hydroxyisothiazole 1-oxide derivative | |
| HK1188145A1 (en) | Novel fused pyridine compounds as casein kinase inhibitors | |
| HK1202288A1 (en) | 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives 2---35- | |
| HK1198586A1 (en) | 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives 6--56--2h-[14]-3- | |
| IL232717A0 (en) | 3-cyanoaryl-1h-pyrrolo[2,3-b]pyridine derivatives | |
| EP2524917A4 (en) | Fused pyridine derivatives | |
| RS55579B1 (en) | Novel pyrazine derivatives | |
| EP2668186A4 (en) | Pharmaceutical composition comprising pyridone derivatives | |
| EP2558094A4 (en) | Pyridone derivatives | |
| HK1187336A1 (en) | Pharmaceutical composition comprising pyridone derivatives | |
| HK1193611A1 (en) | Solid forms of 1,1-dioxo-4-thiomorpholinyl)-[6-[[3(4-fluorophenyl)-5- methyl-4-isoxazolyl]methoxy]-3-pyridinyl]-methanone (1l--4-)-[6-[[3(4-)-5--4-]]-3- ]- | |
| AU2011901088A0 (en) | Door Track | |
| GB201119592D0 (en) | Novel heteroaromatic Derivatives I |